Portage Biotech Inc - PRTG Price Chart

Portage Biotech Inc. (PRTG) operates within an autonomous product cycle, establishing it as a defensive asset independent of global macroeconomic fluctuations. Partnerships with medical centers allow the company to reduce capital expenditures, optimizing free cash flow, which currently stands at 6.82. Securities market dynamics on the GURU.Markets platform reflect the issuer's current quotes. The business relies on the development of universal iNKT platforms for the therapy of metastases and solid tumors.

Portage Biotech Corp - PRTG Price (period 07/04/2022 - 09/04/2025)

PRTG (Portage Biotech Inc): analytical breakdowns and indicator data

- stock value and consensus price forecast:

Price Chart Portage Biotech Inc.|PRTG - Forecast Levels Chart

- issuer market value details:

Market Value Portage Biotech Inc|PRTG - Value Adjusted for Debt and Cash

- balance sheet equity data:

Accounting Value per Share Portage Biotech|PRTG - Total Net Assets|Market Capitalization to Book Value Ratio portagebiotech.com|PRTG - Company Balance Sheet Assets

- debt burden and liquidity indicators:

- financial results and valuation multiples details:

PRTG - Final Profit|Projected Future Earnings Portage Biotech Inc.|PRTG - P/E Multiple|Future Price to Earnings Portage Biotech|PRTG - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Portage Biotech Inc|PRTG - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Portage Biotech|PRTG - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months portagebiotech.com|PRTG - Earnings per share growth this year|Earnings growth forecast for next year Portage Biotech Inc.

Analysis of all company metrics:PRTG Portage Biotech Inc.

The price reflects the current market value of Portage Biotech Inc. (PRTG) capital, capturing the real-time balance of supply and demand to assess investment expectations. By analyzing the share price action, an investor can forecast the company's future capitalization, which correlates directly with clinical trial results and the potential to establish pricing power for unique cancer immunotherapy drugs.

Who Portage Biotech Inc. competes with